There is no Press for this Ticker
Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive drug for chronic pain and inflammation. ATB-352, the second drug in pipeline, targets the urgent global need for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Its operating segment includes Antibe and Citagenix. The company generates maximum revenue from Citagenix segment and geographically from Canada. Citagenix segment is a marketer and distributor of regenerative medicines serving the dental and orthopaedic market places.

Related Companies

TickerCompanyChg %Mkt Cap
ATBPFAntibe Therapeutics-0.34%

Antibe Therapeutics Frequently Asked Questions

Q

How do I buy Antibe Therapeutics (ATBPF) stock?

A

You can purchase shares of Antibe Therapeutics (OTC: ATBPF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Antibe Therapeutics's (ATBPF) competitors?

A

There are no as such competitors for Antibe Therapeutics.

Q

What is the target price for Antibe Therapeutics (ATBPF) stock?

A

There is no analysis for Antibe Therapeutics

Q

Current Stock Price for Antibe Therapeutics (ATBPF)?

A

The stock price for Antibe Therapeutics (OTC: ATBPF) is $3.03269 last updated Mon Jun 21 2021 19:31:18 GMT+0000 (Coordinated Universal Time).

Q

Does Antibe Therapeutics (ATBPF) pay a dividend?

A

There are no upcoming dividends for Antibe Therapeutics.

Q

When is Antibe Therapeutics (OTC:ATBPF) reporting earnings?

A

Antibe Therapeutics does not have any upcoming earnings scheduled.

Q

Is Antibe Therapeutics (ATBPF) going to split?

A

There is no upcoming split for Antibe Therapeutics.

Q

What sector and industry does Antibe Therapeutics (ATBPF) operate in?

A

Antibe Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.